Back to Home
Skip navigation links
PROJECT INFORMATION
STATISTICS
DATA MANAGEMENT
LINKS
Back to Home site

Sign In


Skip navigation links
PROJECT INFORMATION
WORK PACKAGESExpand WORK PACKAGES
DELIVERABLES
DISSEMINATION
FINAL REPORTSExpand FINAL REPORTS
STATISTICSExpand STATISTICS
DATA MANAGEMENT
ROAD MAP INITIATIVE
PARTNERSExpand PARTNERS
WHO IS WHO
EU FUNDING
Patient Support Groups
Donor Registries
Clinical Trials Groups
General Trials Information
National BMT Registries

 WP3: Overcoming ethical problems of trans-national access

 
The Centre for Professional Ethics at the University of Central Lancashire (UCLAN) in the UK has been working closely with the EBMT to evaluate how to overcome ethical and legal challenges for trans-national SCT research. David Coles and Doris Schroeder are the lead participants from UCLAN.
 

There are 2 key deliverables under this work package are:

  • a workshop and report on national legislative uptake of the EU Clinical Trials Directive, describing discrepancies in ethical/legal guidelines and regulations that hinder trans-national cooperation in research in SCT
  • a workshop and report on issues arising in relation to Informed Consent and Data Protection in the context of trans-national SCT research

Project Report:

A literature review on material relevant to the implementation of the Clinical trials Directive across Europe and its impact on national regulatory systems and multinational academic clinical trials, particularly for SCT research has been completed.

A questionnaire aimed at gathering information on the legal and regulatory aspects of trans-national access to clinical trials was prepared and implemented as a digitised web questionnaire in the ProMISe software in collaboration with Work Package 4. At the beginning of February all EBMT transplant centres in the EU, Norway and Switzerland were invited to participate in the survey. The findings and participants recommendations were presented in March 2008 at the CLINT Workshop in Florence. One of the outcomes of this workshop was to suggest that two shorter, more focused follow-up surveys be sent to two groups: EBMT investigators and national study groups, to collect additional data. By the end of the study, EBMT will identify key problems, develop methodologies, and make policy recommendations to facilitate the measures required to conduct academic trans-European clinical trials in stem-cell transplantation. A report will be produced as deliverable 16 at month 18 and will be shared with EU and national authority officials.

Over the course of 2008 a similar evaluation will be completed on issues related to Informed Consent and Data protection for discussion during a second workshop session at the EBMT 2009 meeting in Göteborg.

Deliverables:  April 2007 – September 2009

  Deliverable Due date Evidence
 N/a Literature review
Month 6 Literature review
 D33 (refWP6) Workshop on Clinical Trials governance in Europe Month 12 Link to programme
 D16 Report on national legislatures and EU Directive on Clinical Trials
Month 18 Final report incorporating D16 & D6 produced at month 30
 D 26 Report on informed consent and data protection in the context of transnational SCT research
Month 24 Final report incorporating D16 and D6 produced at month 30


 Press Releases

CLINT Project website goes live
EBMT investigates challenges
Better Late Than Never
Road Map Initiative for Clinical Research in Europe
Review of the European Clinical Trials Directive
 
Copyright © 2009 EBMT